Cargando…

Regulation of androgen receptor splice variant AR3 by PCGEM1

The androgen receptor (AR) is required for prostate development and is also a major driver of prostate cancer pathogenesis. Thus androgen deprivation therapy (ADT) is the mainstay of treatment for advanced prostate cancer. However, castration resistance due to expression of constitutively active AR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ziqiang, Zhou, Nanjiang, Huang, Jianguo, Ho, Tsui-Ting, Zhu, Zhuxian, Qiu, Zhongmin, Zhou, Xinchun, Bai, Chunxue, Wu, Fangting, Xu, Min, Mo, Yin-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941255/ https://www.ncbi.nlm.nih.gov/pubmed/26848868 http://dx.doi.org/10.18632/oncotarget.7139

Ejemplares similares

Regulation of PCGEM1 by p54/nrb in prostate cancer
por: Ho, Tsui-Ting, et al.
Publicado: (2016)

The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo
por: Parolia, Abhijit, et al.
Publicado: (2015)

Racial Differences in Androgen Receptor (AR) and AR Splice Variants (AR-SVs) Expression in Treatment-Naïve Androgen-Dependent Prostate Cancer
por: Khan, Farhan, et al.
Publicado: (2023)

Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines
por: Ho, Tsui-Ting, et al.
Publicado: (2015)

LncRNA loc285194 is a p53-regulated tumor suppressor
por: Liu, Qian, et al.
Publicado: (2013)

Gut microbiota regulate tumor metastasis via circRNA/miRNA networks
por: Zhu, Zhuxian, et al.
Publicado: (2020)

Androgen receptor splice variants circumvent AR blockade by microtubule-targeting agents
por: Zhang, Guanyi, et al.
Publicado: (2015)

Linc-RoR promotes c-Myc expression through hnRNP I and AUF1
por: Huang, Jianguo, et al.
Publicado: (2016)

AR Splicing Variants and Resistance to AR Targeting Agents
por: Kanayama, Mayuko, et al.
Publicado: (2021)

Antiandrogen-Equipped Histone Deacetylase Inhibitors Selectively Inhibit Androgen Receptor (AR) and AR-Splice Variant (AR-SV) in Castration-Resistant Prostate Cancer (CRPC)
por: Chandrasekaran, Balaji, et al.
Publicado: (2023)

Cistrome and transcriptome analysis identifies unique androgen receptor (AR) and AR-V7 splice variant chromatin binding and transcriptional activities
por: Basil, Paul, et al.
Publicado: (2022)

Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
por: Narayanan, Ramesh
Publicado: (2020)

Androgen receptor and its splice variant, AR-V7, differentially induce mRNA splicing in prostate cancer cells
por: Rana, Manjul, et al.
Publicado: (2021)

Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells
por: Shafi, Ayesha A., et al.
Publicado: (2015)

The RNA-binding protein Sam68 regulates expression and transcription function of the androgen receptor splice variant AR-V7
por: Stockley, Jacqueline, et al.
Publicado: (2015)

Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases
por: Kallio, Heini M. L., et al.
Publicado: (2018)

AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression
por: Li, Yingming, et al.
Publicado: (2012)

Author Correction: Androgen receptor and its splice variant, AR-V7, differentially induce mRNA splicing in prostate cancer cells
por: Rana, Manjul, et al.
Publicado: (2021)

Role of androgen receptor splice variant 7 (AR-V7) in prostate cancer resistance to 2(nd) generation androgen receptor signaling inhibitors
por: Zhu, Yezi, et al.
Publicado: (2020)

Decoding the androgen receptor splice variants
por: Lu, Changxue, et al.
Publicado: (2013)

α-Mangostin Promotes In Vitro and In Vivo Degradation of Androgen Receptor and AR-V7 Splice Variant in Prostate Cancer Cells
por: Nauman, Mirielle C., et al.
Publicado: (2023)

Role of androgen receptor splice variants in prostate cancer metastasis
por: Xu, Jin, et al.
Publicado: (2016)

Microbiome and spatially resolved metabolomics analysis reveal the anticancer role of gut Akkermansia muciniphila by crosstalk with intratumoral microbiota and reprogramming tumoral metabolism in mice
por: Zhu, Zhuxian, et al.
Publicado: (2023)

Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients
por: Cattrini, Carlo, et al.
Publicado: (2019)

Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer
por: Wüstmann, Neele, et al.
Publicado: (2023)

SUN-LB136 A Comparison of Androgen Receptor Splice Variant, AR-V7, and Glucocorticoid Receptor Activity in Prostate Cancer
por: Dash, Amit K, et al.
Publicado: (2020)

Replication study: androgen receptor splice variants determine taxane sensitivity in prostate cancer
por: Shan, Xiaochuan, et al.
Publicado: (2018)

Splice Variants of Androgen Receptor and Prostate Cancer
por: Caffo, Orazio, et al.
Publicado: (2016)

Clinical characteristics, AR gene variants, and functional domains in 64 patients with androgen insensitivity syndrome
por: Liu, Q., et al.
Publicado: (2022)

lncRNA PCGEM1 strengthens anti-inflammatory and lung protective effects of montelukast sodium in children with cough-variant asthma
por: Xu, Zhenxing, et al.
Publicado: (2020)

The lncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer
por: Prensner, John R., et al.
Publicado: (2014)

LncRNA PCGEM1 in Human Cancers: Functions, Mechanisms and Promising Clinical Utility
por: Su, Yuanshuai, et al.
Publicado: (2022)

Diverse roles of androgen receptor (AR) domains in AR-mediated signaling
por: Claessens, Frank, et al.
Publicado: (2008)

LncRNA AK023948 is a positive regulator of AKT
por: Koirala, Pratirodh, et al.
Publicado: (2017)

Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells
por: Khurana, Namrata, et al.
Publicado: (2020)

A New Trick of an Old Molecule: Androgen Receptor Splice Variants Taking the Stage?!
por: Guo, Zhiyong, et al.
Publicado: (2011)

Novel compound variants of the AR and MAP3K1 genes are related to the clinical heterogeneity of androgen insensitivity syndrome
por: Cheng, Yiping, et al.
Publicado: (2020)

A Compendium of AR Splice Variants in Metastatic Castration-Resistant Prostate Cancer
por: Isebia, Khrystany T., et al.
Publicado: (2023)

COVID-19 vaccination is associated with enhanced efficacy of anti-PD-(L)1 immunotherapy in advanced NSCLC patients: a real-world study
por: Qian, Yunfei, et al.
Publicado: (2023)

Expression of androgen receptor splice variants in clinical breast cancers
por: Hickey, Theresa E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1bh0roh976uijeo9oei5fcumsr